We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

208 hedge funds and large institutions have $1.18B invested in Immunogen Inc in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 61 increasing their positions, 61 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

660% more call options, than puts

Call options by funds: $16.9M | Put options by funds: $2.22M

37% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 27

5% more funds holding

Funds holding: 198 → 208 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 61

3% less capital invested

Capital invested by funds: $1.22B → $1.18B (-$41.6M)

Holders
208
Holders Change
+10
Holders Change %
+5.05%
% of All Funds
4.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
37
Increased
61
Reduced
61
Closed
27
Calls
$16.9M
Puts
$2.22M
Net Calls
+$14.6M
Net Calls Change
+$14.6M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$39.6M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$18.5M
3
BlackRock
BlackRock
New York
+$10.1M
4
BNP Paribas Asset Management
BNP Paribas Asset Management
France
+$9.02M
5
Millennium Management
Millennium Management
New York
+$5.57M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$22.5M
2
Franklin Resources
Franklin Resources
California
-$16.9M
3
O
OrbiMed
New York
-$13.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.6M
5
ClearBridge Investments
ClearBridge Investments
New York
-$10.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$1.57M +$645K +67,131 +68%
CS
52
Credit Suisse
Switzerland
$1.37M -$436K -45,402 -24%
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$1.36M +$5.77K +600 +0.4%
PPA
54
Parametric Portfolio Associates
Washington
$1.31M +$592K +61,585 +80%
Fisher Asset Management
55
Fisher Asset Management
Washington
$1.3M +$1.35K +141 +0.1%
State of Wisconsin Investment Board
56
State of Wisconsin Investment Board
Wisconsin
$1.24M – – –
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$1.23M +$132K +13,759 +12%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$1.19M +$7.7K +801 +0.6%
TFCP
59
Twin Focus Capital Partners
Massachusetts
$1.07M – – –
Principal Financial Group
60
Principal Financial Group
Iowa
$1.05M +$70.2K +7,304 +7%
Natixis Advisors
61
Natixis Advisors
Massachusetts
$1.03M -$245K -25,494 -19%
Citigroup
62
Citigroup
New York
$994K +$347K +36,147 +53%
Capital Fund Management (CFM)
63
Capital Fund Management (CFM)
France
$954K +$968K +100,704 New
Alyeska Investment Group
64
Alyeska Investment Group
Illinois
$947K +$961K +100,000 New
AIG
65
American International Group
New York
$902K +$113K +11,747 +14%
UBS AM
66
UBS AM
Illinois
$892K +$45.2K +4,700 +5%
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$887K -$13.9K -1,449 -2%
Two Sigma Advisers
68
Two Sigma Advisers
New York
$882K -$2.16M -224,500 -71%
NA
69
Navellier & Associates
Nevada
$876K +$890K +92,538 New
Squarepoint
70
Squarepoint
New York
$849K -$10.6K -1,100 -1%
Janney Montgomery Scott
71
Janney Montgomery Scott
Pennsylvania
$818K +$17.6K +1,835 +2%
DADC
72
D.A. Davidson & Co
Montana
$781K -$36.5K -3,792 -4%
MOACM
73
Mutual of America Capital Management
New York
$748K – – –
Los Angeles Capital Management
74
Los Angeles Capital Management
California
$745K -$33.4K -3,470 -4%
ProShare Advisors
75
ProShare Advisors
Maryland
$742K +$53.3K +5,543 +8%
1 2
3
4 5

IMGN Hedge Fund Activity: Q3 2018 in Review

208 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2018, worth a combined $1.18B — down 3.4% from $1.22B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new IMGN positions and 27 closed out — a net gain of 10 holders — while 61 added to existing stakes and 61 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $39.6M. The largest seller was Capital Research Global Investors, cutting an estimated $22.5M.

  • 208 institutional investors held Immunogen Inc (IMGN) as of Q3 2018, up from 198 in Q2 2018.
  • Funds reported $1.18B of Immunogen Inc stock for Q3 2018, down 3.4% quarter-over-quarter.
  • 37 funds opened new Immunogen Inc positions in Q3 2018 and 27 closed out, a net change of +10 holders.
  • The largest Immunogen Inc buyer in Q3 2018 was Point72 Asset Management, an estimated $39.6M added.
  • The largest Immunogen Inc seller in Q3 2018 was Capital Research Global Investors, an estimated $22.5M sold.

Based on aggregated 13F filings for Q3 2018.